<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-12T11:21:06Z</responseDate>
  <request identifier="oai:figshare.com:article/33974665" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33974665</identifier>
        <datestamp>2026-09-23T17:21:35Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_19</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_106</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Codebook for primary data set.&lt;/p&gt;</dc:title>
          <dc:creator>Jan-Ole Hesselberg (21453807)</dc:creator>
          <dc:creator>Pål Ulleberg (522303)</dc:creator>
          <dc:creator>Øystein Sørensen (4767861)</dc:creator>
          <dc:creator>Knut Inge Fostervold (11509353)</dc:creator>
          <dc:creator>Sigrid Hegna Ingvaldsen (15359171)</dc:creator>
          <dc:creator>Ida Svege (11509356)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Pharmacology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Science Policy</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>general panel membership</dc:subject>
          <dc:subject>average iccs ranged</dc:subject>
          <dc:subject>human judgment rather</dc:subject>
          <dc:subject>structured review formats</dc:subject>
          <dc:subject>stable reviewer tendencies</dc:subject>
          <dc:subject>reviewer age composition</dc:subject>
          <dc:subject>moderate across funders</dc:subject>
          <dc:subject>substantially improve reliability</dc:subject>
          <dc:subject>systematic reviewer characteristics</dc:subject>
          <dc:subject>including reviewer similarity</dc:subject>
          <dc:subject>depth review procedures</dc:subject>
          <dc:subject>matter expertise rather</dc:subject>
          <dc:subject>examines factors associated</dc:subject>
          <dc:subject>slightly lower disagreement</dc:subject>
          <dc:subject>reviewer similarity</dc:subject>
          <dc:subject>review depth</dc:subject>
          <dc:subject>specific rather</dc:subject>
          <dc:subject>review roles</dc:subject>
          <dc:subject>multiple factors</dc:subject>
          <dc:subject>four funders</dc:subject>
          <dc:subject>reliability persist</dc:subject>
          <dc:subject>rater reliability</dc:subject>
          <dc:subject>lower disagreement</dc:subject>
          <dc:subject>application characteristics</dc:subject>
          <dc:subject>yet concerns</dc:subject>
          <dc:subject>variability arose</dc:subject>
          <dc:subject>temporal trends</dc:subject>
          <dc:subject>specific ambiguity</dc:subject>
          <dc:subject>reviewers selected</dc:subject>
          <dc:subject>reviewers disagree</dc:subject>
          <dc:subject>residual level</dc:subject>
          <dc:subject>research area</dc:subject>
          <dc:subject>registered report</dc:subject>
          <dc:subject>rater agreement</dc:subject>
          <dc:subject>program features</dc:subject>
          <dc:subject>primarily due</dc:subject>
          <dc:subject>leveraging data</dc:subject>
          <dc:subject>level ambiguity</dc:subject>
          <dc:subject>inherent variability</dc:subject>
          <dc:subject>greater responsibility</dc:subject>
          <dc:subject>grant evaluations</dc:subject>
          <dc:subject>expert reviews</dc:subject>
          <dc:subject>clearer criteria</dc:subject>
          <dc:subject>assessments conducted</dc:subject>
          <dc:subject>also associated</dc:subject>
          <dc:subject>absolute magnitude</dc:subject>
          <dc:subject>1 percent</dc:subject>
          <dc:description>&lt;p&gt;Codebook describing the data in the primary data set used as the starting point for the analysis script (see &lt;a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0356108#pone.0356108.s005" target="_blank"&gt;S2 File&lt;/a&gt;).&lt;/p&gt; &lt;p&gt;(XLSX)&lt;/p&gt;</dc:description>
          <dc:date>2026-09-23T17:21:34Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pone.0356108.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Codebook_for_primary_data_set_p_/33974665</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
